Tetherex Pharmaceuticals Corp — Form D
Tetherex Pharmaceuticals Corp of OKLAHOMA CITY, OK, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-06. The offering totals $50.0M, of which $43.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-03-06
- Form: D
- Accession: 0001140361-18-012258
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $43.0M
- Remaining: $7.0M
- Minimum investment: $10K
- Investors: 240
- Date of first sale: 2018-02-20
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-307053
Issuer
- Name: Tetherex Pharmaceuticals Corp
- CIK: 0001634581
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 840 RESEARCH PARKWAY, SUITE 516, OKLAHOMA CITY, OK, 73104
- Phone: 405-319-8195
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| David Facloner | Executive Officer | Edmond, OK |
| Todd Foley | Director | South San Francisco, CA |
| Richard Alvarez | Executive Officer | Phoenix, AZ |
| Russell Rother | Executive Officer | Oklahoma City, OK |
| Scott Rollins, Ph.D. | Director | OKLAHOMA CITY, OK |
| Scott Rollins, Ph.D. | Executive Officer | OKLAHOMA CITY, OK |
| Rodger McEver, M.D. | Director | OKLAHOMA CITY, OK |
| Scott Samara | Director | Oklahoma City, OK |
| Philip Jones, M.D. | Director | Norman, OK |
| Russell Rother, Ph.D. | Director | OKLAHOMA CITY, OK |
| Russell Rother, Ph.D. | Executive Officer | OKLAHOMA CITY, OK |
| David Keiser | Director | Madison, CT |
| Jonathan Stocker, Ph.D. | Executive Officer | Cary, NC |
Other filings by this issuer (4)
More